Effect of bioactive borate glass microstructure on bone regeneration, angiogenesis, and hydroxyapatite conversion in a rat calvarial defect model.

Borate bioactive glasses are biocompatible and enhance new bone formation, but the effect of their microstructure on bone regeneration has received little attention. In this study scaffolds of borate bioactive glass (1393B3) with three different microstructures (trabecular, fibrous, and oriented) were compared for their capacity to regenerate bone in a rat calvarial defect model. 12weeks post-implantation the amount of new bone, mineralization, and blood vessel area in the scaffolds were evaluated using histomorphometric analysis and scanning electron microscopy. The amount of new bone formed was 33%, 23%, and 15%, respectively, of the total defect area for the trabecular, oriented, and fibrous microstructures. In comparison, the percent new bone formed in implants composed of silicate 45S5 bioactive glass particles (250-300μm) was 19%. Doping the borate glass with copper (0.4 wt.% CuO) had little effect on bone regeneration in the trabecular and oriented scaffolds, but significantly enhanced bone regeneration in the fibrous scaffolds (from 15 to 33%). The scaffolds were completely converted to hydroxyapatite within the 12week implantation. The amount of hydroxyapatite formed, 22%, 35%, and 48%, respectively, for the trabecular, oriented, and fibrous scaffolds, increased with increasing volume fraction of glass in the as-fabricated scaffold. Blood vessels infiltrated into all the scaffolds, but the trabecular scaffolds had a higher average blood vessel area compared with the oriented and fibrous scaffolds. While all three scaffold microstructures were effective in supporting bone regeneration, the trabecular scaffolds supported more bone formation and may be more promising in bone repair.

[1]  Larry L. Hench,et al.  Bonding mechanisms at the interface of ceramic prosthetic materials , 1971 .

[2]  Delbert E. Day,et al.  Transformation of Borate Glasses into Biologically Useful Materials , 2003 .

[3]  T Theophanides,et al.  Copper and carcinogenesis. , 2002, Critical reviews in oncology/hematology.

[4]  H Takita,et al.  Effects of geometry of hydroxyapatite as a cell substratum in BMP-induced ectopic bone formation. , 2000, Journal of biomedical materials research.

[5]  Wenhai Huang,et al.  Teicoplanin-loaded borate bioactive glass implants for treating chronic bone infection in a rabbit tibia osteomyelitis model. , 2010, Biomaterials.

[6]  D. Day,et al.  In Vitro Bioactive Characteristics of Borate‐Based Glasses with Controllable Degradation Behavior , 2007 .

[7]  L. C. Li,et al.  Strontium borate glass: potential biomaterial for bone regeneration , 2010, Journal of The Royal Society Interface.

[8]  Julian R Jones,et al.  Review of bioactive glass: from Hench to hybrids. , 2013, Acta biomaterialia.

[9]  Q. Fu,et al.  Oriented bioactive glass (13-93) scaffolds with controllable pore size by unidirectional freezing of camphene-based suspensions: Microstructure and mechanical response. , 2011, Acta biomaterialia.

[10]  A. Kostakis,et al.  Rat Epigastric Flap Survival and VEGF Expression after Local Copper Application , 2007, Plastic and reconstructive surgery.

[11]  Yong-cheng Hu,et al.  Osteostimulation of bioglass. , 2009, Chinese medical journal.

[12]  Dietmar W. Hutmacher,et al.  Scaffold design and fabrication technologies for engineering tissues — state of the art and future perspectives , 2001, Journal of biomaterials science. Polymer edition.

[13]  G. Gole,et al.  Angiogenic factors and their assay: activity of formyl methionyl leucyl phenylalanine, adenosine diphosphate, heparin, copper, and bovine endothelium stimulating factor. , 1983, Microvascular research.

[14]  Wenhai Huang,et al.  Kinetics and mechanisms of the conversion of silicate (45S5), borate, and borosilicate glasses to hydroxyapatite in dilute phosphate solutions , 2006, Journal of materials science. Materials in medicine.

[15]  R. Carano,et al.  Angiogenesis and bone repair. , 2003, Drug discovery today.

[16]  D. Kaplan,et al.  Porosity of 3D biomaterial scaffolds and osteogenesis. , 2005, Biomaterials.

[17]  E. Place,et al.  Complexity in biomaterials for tissue engineering. , 2009, Nature materials.

[18]  Delbert E Day,et al.  Bioactive glass in tissue engineering. , 2011, Acta biomaterialia.

[19]  D. Day,et al.  Reaction of sodium calcium borate glasses to form hydroxyapatite , 2007, Journal of materials science. Materials in medicine.

[20]  J. Barralet,et al.  Bioinorganics and biomaterials: bone repair. , 2011, Acta biomaterialia.

[21]  J. Kanczler,et al.  Osteogenesis and angiogenesis: the potential for engineering bone. , 2008, European cells & materials.

[22]  Q. Fu,et al.  Silicate, borosilicate, and borate bioactive glass scaffolds with controllable degradation rate for bone tissue engineering applications. I. Preparation and in vitro degradation. , 2010, Journal of biomedical materials research. Part A.

[23]  L. Bonewald,et al.  Evaluation of bone regeneration, angiogenesis, and hydroxyapatite conversion in critical-sized rat calvarial defects implanted with bioactive glass scaffolds. , 2012, Journal of biomedical materials research. Part A.

[24]  Aldo R Boccaccini,et al.  A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics. , 2011, Biomaterials.

[25]  S. Wolfe.  Autogenous bone grafts versus alloplastic material in maxillofacial surgery. , 1982, Clinics in plastic surgery.

[26]  H. Takita,et al.  Geometry of Carriers Controlling Phenotypic Expression in BMP-Induced Osteogenesis and Chondrogenesis , 2001, The Journal of bone and joint surgery. American volume.

[27]  G. Hu.  Copper stimulates proliferation of human endothelial cells under culture , 1998, Journal of cellular biochemistry.

[28]  Eleftherios Tsiridis,et al.  Bone substitutes: an update. , 2005, Injury.

[29]  A. Harris,et al.  The Role of Copper in Tumour Angiogenesis , 2005, Journal of Mammary Gland Biology and Neoplasia.

[30]  R. Cabrini,et al.  Biological performance of boron-modified bioactive glass particles implanted in rat tibia bone marrow , 2006, Biomedical materials.

[31]  T. K. Hunt,et al.  Copper-induced vascular endothelial growth factor expression and wound healing. , 2002, American journal of physiology. Heart and circulatory physiology.

[32]  Larry L. Hench,et al.  The story of Bioglass® , 2006, Journal of materials science. Materials in medicine.

[33]  Delbert E Day,et al.  Mechanical and in vitro performance of 13-93 bioactive glass scaffolds prepared by a polymer foam replication technique. , 2008, Acta biomaterialia.

[34]  Yoshinori Kuboki,et al.  Geometry of Artificial ECM: Sizes of Pores Controlling Phenotype Expression in BMP-Induced Osteogenesis and Chondrogenesis , 2002, Connective tissue research.

[35]  M. Linder.  The relationship of copper to DNA damage and damage prevention in humans. , 2012, Mutation research.

[36]  Keiichi Kuroki,et al.  Silicate, borosilicate, and borate bioactive glass scaffolds with controllable degradation rate for bone tissue engineering applications. II. In vitro and in vivo biological evaluation. , 2010, Journal of biomedical materials research. Part A.

[37]  D. Day,et al.  Mechanism for converting Al2O3-containing borate glass to hydroxyapatite in aqueous phosphate solution. , 2009, Acta biomaterialia.

[38]  H. Kim,et al.  Bone formation controlled by biologically relevant inorganic ions: role and controlled delivery from phosphate-based glasses. , 2013, Advanced drug delivery reviews.